• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table 2Priority medication comparisons included for each of the key questions

Main interventionComparisons
Monotherapy as main interventionMetformin
  • Thiazolidinedione
  • Sulfonylurea
  • DPP-4 inhibitor
  • Meglitinides
  • GLP-1 agonist
  • Combination of metformin plus thiazolidinedione
  • Combination of metformin plus sulfonylurea
  • Combination of metformin plus DPP-4 inhibitor
  • Combination of metformin plus meglitinides
Thiazolidinedione
  • Different thiazolidinedione
  • Sulfonylurea
  • DPP-4 inhibitor
  • Meglitinides
  • GLP-1 agonist
Sulfonylurea
  • DPP-4 inhibitor
  • Meglitinides
  • GLP-1 agonist
DPP-4 inhibitors
  • DPP-4 inhibitor
  • Meglitinides
  • GLP-1 agonist
Meglitinides
  • GLP-1 agonist
Combination therapy as main interventionCombination of metformin plus (a thiazolidinedione or a sulfonylurea or a meglitinide or DPP-4 inhibitor or GLP-1 agonist or a basal insulin or a premixed insulin)
  • Combination of metformin plus (a thiazolidinedione or a sulfonylurea or a meglitinides or DPP-4 inhibitor or GLP-1 agonist or a basal insulin or a premixed insulin)
Combination of metformin plus (a thiazolidinedione or a sulfonylurea or a meglitinides or DPP-4 inhibitor or GLP-1 agonist or a basal insulin or a premixed insulin)
  • Combination of a thiazolidinedione plus (a sulfonylurea or a meglitinides or DPP-4 inhibitor or GLP-1 agonist)

DPP-4 inhibitor = dipeptidyl peptidase-4 inhibitor; GLP-1 agonist = glucagon-like peptide-1 receptor agonist

From: Introduction

Cover of Oral Diabetes Medications for Adults With Type 2 Diabetes: An Update
Oral Diabetes Medications for Adults With Type 2 Diabetes: An Update [Internet].
Comparative Effectiveness Reviews, No. 27.
Bennett WL, Wilson LM, Bolen S, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.